Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
Access all of the press releases and statements related to the work of the Vaccine Alliance
27 March 2019
Leadership training for supply chain managers expands to five African countries
14 March 2019
Pneumococcal vaccine price drops for third year running
12 March 2019
Gavi and Zenysis Technologies to bring data and artificial intelligence to immunisation programmes
5 March 2019
Gavi signs new cooperation agreement with Japan International Cooperation Agency
13 February 2019
UK to host Gavi's donor pledging conference in 2020
12 February 2019
Ethiopia introduces measles vaccine second dose with support from Gavi
15 January 2019
Iceland pledges US$1 million to immunise children in Malawi
14 December 2018
Japan to send Junior Professional Officers to work at Gavi
12 December 2018
Coalition for Epidemic Preparedness Innovation turns to IFFIm to accelerate funding for new vaccine development
Global health leaders hail immunisation as shortest path to healthy lives
11 December 2018
Gavi and Germany partner to harness blockchain technology
Gavi and Mastercard join forces to reach more children with lifesaving vaccines